12:45 PM EDT, 04/04/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday it appointed Sanjay Keswani as chief medical officer, effective June 2.
He will succeed Eiry Roberts, who will transition to the role of a strategic advisor, the company said. Keswani was most recently the president and CEO of ImmunoBrain.
Price: 95.40, Change: -7.49, Percent Change: -7.28